PRESS RELEASES
APMGR trage încă un semnal de alarmă referitor la taxa clawback
București 08.11.2019 - Asociația Producătorilor de Medicamente Generice din România (APMGR), trage încă un semnal de alarmă referitor la taxa clawback, taxa ce a ajuns la 26,49%, nivel total nesustenabil pentru medicamentele generice. Producătorii de medicamente...
International Health Forum: APMGR demands the withdrawal of abusive fiscal policies in the pharmaceutical sector
BUCHAREST, SEPTEMBER 15TH, 2015 - THE ROMANIAN ASSOCIATION OF GENERIC DRUG MANUFACTURERS (APMGR), representing generic drug manufacturing companies from Romania, demands that authorities withdraw abusive fiscal policies existing in the pharmaceutical field, in order...
07.05.2014 – APMGR calls for more transparency in calculating the clawback tax by reporting the number of units settled by CNAS
THE CLAWBACK TAX ON Q1 2014 CONTINUES TO BE UNREASONABLY HIGH, AS THE PERCENTAGE "P" IN THE CALCULATION OF THE CLAWBACK IS OVER 20% OF THE SALE OF REIMBURSED MEDICINES APMGR REQUIRES THE NATIONAL HEALTH INSURANCE HOUSE (NHIH) TO BE MORE TRANSPARENT IN THE WAY THE...
09.10.2013 – EGA’s vision of the future for the generic and biosimilar medicine industries in europe
BRUSSELS, 9 OCTOBER 2013 - On Tuesday 8th October, the European Generic medicines Association (EGA) launched its industrial policy vision for the future of the generic and biosimilar medicine industries in Europe at the EGA Industrial Policy Conference gathering...
01.07.2013 – A new era of biosimilar medicines is about to start: CHMP positive scientific opinion for first biosimilar monoclonal antibodies
BRUSSELS, 1 July 2013 - The EGA welcomes the European Medicines Agency’s recommendation to the European Commission to approve the first two infliximab biosimilar products, both referenced to Remicade©. “This is a key milestone in the history of medicines in the EU,...
13.06.2013 – Only increased focus on generic and biosimilar medicines can make european healthcare sustainable
ATHENS, 13 June 2013 - Addressing delegates at the 19th EGA Annual Conference in Athens, Gudbjorg Edda Eggertsdottir stressed that generic and biosimilar medicines companies ensuring high-quality manufacturing jobs and know-how should remain in Europe; benefiting...